Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-15

Clinical Trial Update: The Impact of Psilocybin on Pain in Fibromyalgia Patients [NA]

View source ↗

Summary

A Maastricht University–sponsored clinical trial is currently recruiting to assess whether psilocybin can reduce pain in individuals with fibromyalgia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: Maastricht University | Conditions: Fibromyalgia | NA | Status: RECRUITING